Silo Pharma, Inc. announced encouraging preliminary results from an ongoing study of its SP-26 ketamine extended-release rods, which are being evaluated for safety and pharmacokinetics after being ...
ENGLEWOOD CLIFFS, NJ, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (SILO) (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results